| Previous Close | 82.24 |
| Open | 82.14 |
| Bid | 71.12 x 1000 |
| Ask | 71.74 x 44000 |
| Day's Range | 81.63 - 82.65 |
| 52 Week Range | 66.72 - 92.97 |
| Volume | 1,642,238 |
| Avg. Volume | 2,269,652 |
| Market Cap | 99.77B |
| Beta | 0.74 |
| PE Ratio (TTM) | 11.32 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 3.30 (3.39%) |
| Ex-Dividend Date | 2017-05-16 |
| 1y Target Est | N/A |
- Motley Fool•yesterday
What's the Most Important Drug in Regeneron Pharmaceuticals' Pipeline?
Regeneron Pharmaceuticals has a slew of clinical trials going on, and studies evaluating REGN-2810 could be the most important.
- Zacks•2 days ago
Biogen & 6 Other Multiple Sclerosis Drug Stocks in Focus: Here's Why
Late last week, Biogen (BIIB) and six other pharma and biotech stocks were in the news due to the pricing of their multiple sclerosis ("MS") drugs.
- Market Realist•5 days ago
A Look at Sanofi Pasteur’s Performance in 2Q17
Sanofi Pasteur, Sanofi’s (SNY) human vaccine business, reported 26.2% revenue growth at constant exchange rates to 1.0 billion euros in 2Q17. Sanofi Pasteur reported growth across all product franchises ...
